NCT05272865: Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC |
|
|
| Not yet recruiting | 1/2 | 334 | RoW | Pharmacokinetic and pharmacodynamic profile of THC oral formulations with Dronabinol as comparator, Administration of different Cannabis oral formulations with THC as compared with Active comparator (DRONABINOL) | LaSanta S A S | Nausea Post Chemotherapy, Vomiting, Cancer Pain, Cancer Related Pain, Neoplasms | 02/24 | 10/24 | | |
| Recruiting | N/A | 400 | US | There is no intervention, There are no interventions | University of Pennsylvania, MOUNT SINAI HOSPITAL, University of North Carolina, Northwestern University, University of New Mexico, Stanford University, The University of Texas Health Science Center at San Antonio, Ohio State University, Yale University, Albert Einstein College of Medicine, Oregon Health and Science University, Lehigh Valley Health Network, University of Arkansas, University of Southern California, University of Virginia, Regeneron Pharmaceuticals, Boehringer Ingelheim, GlaxoSmithKline, Gilead Sciences, Juvenile Diabetes Research Foundation, Novo Nordisk A/S | Diabetic Nephropathies, Diabetic Glomerulosclerosis | 12/24 | 06/25 | | |
NCT05569005: Effect of Switching From Cigarette Smoking to THS on Disease Progression in Mild to Moderate COPD Subjects With Chronic Bronchitis Symptoms. |
|
|
| Terminated | N/A | 715 | Europe, Japan, US, RoW | THS use, Tobacco Heating System 3.0, Cigarette, Smoking Abstinence | Philip Morris Products S.A. | COPD, Smoking, Tobacco Use | 09/24 | 09/24 | | |